DETECTION OF UNNOTIFIED ADVERSE DRUG REACTIONS (ADR). ACTIVE PHARMACOVIGILANCE (APV)

被引：0
|
作者：
Fernandez del Campo, C. Boada [1 ]
Rodriguez Jimenez, C. [1 ]
Sanchez Colomer, M. Garcia [2 ]
Fernandez Quintana, E. [2 ]
Masiero Aparicio, P. [1 ]
Herrera Herrera, J. [1 ]
Garcia Saiz, M. M. [1 ]
机构：
[1] Hosp Univ Canarias, Tenerife, Spain
[2] Ctr Auton Farmacovigilancia & Informac Terapeut C, Tenerife, Spain
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E133 / E133
页数：1
相关论文
共 50 条
  • [21] Adverse drug reactions of methylphenidate in French Pharmacovigilance Database
    Herlem, E.
    Marchaisseau, V.
    Germain, M. L.
    Trenque, T.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 55 - 55
  • [22] Adverse Drug Reactions of Ranitidine: A Pharmacovigilance Study in Korea
    Park, Kyung Hee
    Sim, Da Woon
    Park, Hye Jung
    Jeong, Kyoung-Yong
    Lee, Jae-Hyun
    Park, Jung-Won
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB47 - AB47
  • [23] Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection
    Khan, Lateef M.
    Al-Harthi, Sameer E.
    Alkreathy, Huda M.
    Osman, Abdel-Moneim M.
    All, Ahmed S.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (05) : 515 - 522
  • [24] Pharmacovigilance in the digital era : A machine learning approach for early detection of adverse drug reactions
    Panda, B. K.
    Niranjane, Pornima B.
    Mali, D. P.
    Bainalwar, Prachi A.
    [J]. JOURNAL OF STATISTICS AND MANAGEMENT SYSTEMS, 2024, 27 (02) : 429 - 440
  • [25] Adverse Drug Reactions to Antibiotics in the DRC Pharmacovigilance System
    Bapite, K. A.
    Ntamabyaliro, N. P.
    Lula, N. Y.
    Belebinda, P. D.
    Mboma, M. O.
    Mwanga, M. A.
    Tona, L. G.
    [J]. DRUG SAFETY, 2012, 35 (10) : 947 - 947
  • [26] Drugs, Adverse Drug Reactions and PharmacoVigilance in the Adventures of Tintin
    Montastruc, J. L.
    Damase-Michel, C.
    Lacroix, I.
    Durrieu, G.
    Montastruc, F.
    Sommet, A.
    Bagheri, H.
    Du Plantier, J. M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 90 - 90
  • [27] Cutaneous Adverse Drug Reactions in a Third Level Center: An Active Pharmacovigilance Institutional Program in Colombia
    Arias, S.
    Manosalva, J.
    Amaya, S.
    Alvarez, S.
    Arias, M.
    Briceno, W.
    [J]. DRUG SAFETY, 2019, 42 (10) : 1276 - 1276
  • [28] Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool
    Alshehail, Bashayer
    Al Jamea, Zainab
    Chacko, Royes
    Alotaibi, Fawaz
    Ismail, Nadia
    Alshayban, Dhafer
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (04) : 407 - 413
  • [29] The Study of Adverse Drug Reactions in the In-Patients of Medicine Department of A Tertiary Care Teaching Hospital and the Significance of Pharmacovigilance in Reporting Adr
    Yeshwanth, G.
    Venkateshwarlu
    Thomas, Zachariah
    Madhusudhan, S.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S207 - S207
  • [30] ADVERSE DRUG REACTIONS ASSOCIATED TO HYDROXYCHLOROQUINE AND REMDESIVIR IN COVID-19 PATIENTS: ANALYSIS OF REPORTED ADR TO THE PORTUGUESE PHARMACOVIGILANCE SYSTEM
    Ivos, R.
    Ribeiro-Vaz, I
    Polonia, J.
    Silva, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S90 - S90
12345